PURCHASE ORDER

KAISER FOUNDATION HOSPITALS - ANALYSIS TO EVALUATE THE EFFECTIVENESS OF A SEROGROUP B OUTER MEMBRANE VESICLE MENINGOCOCCAL VACCINE AGAINST GONORRHEA

PIID: 75D30121P11283
Effective Date: Aug 13, 2021End Date: Closed on Aug 12, 2022
Award $
$200K
Vendor
KAISER FOUNDATION HOSPITALS
NAICS
518210

Key Details

Dollars Obligated
$200,350
Awarding Sub-Agency
Centers for Disease Control and Prevention
NAICS Code
518210
Place of Performance
CA

Description

ANALYSIS TO EVALUATE THE EFFECTIVENESS OF A SEROGROUP B OUTER MEMBRANE VESICLE MENINGOCOCCAL VACCINE AGAINST GONORRHEA

Context & Analysis

Department of Health and Human Services obligated $200,350 to KAISER FOUNDATION HOSPITALS for analysis to evaluate the effectiveness of a serogroup b outer membrane vesicle meningococcal vaccine against gonorrhea. The award is classified under NAICS 518210 and issued as a purchase order contract. Performance is located in CA. This award is one of several similar procurements from Department of Health and Human Services under NAICS 518210 — related awards are listed below.

Contractor Information

UEI: P1RTMASB37B5

Stay Updated

Get notified about new opportunities matching your interests.

Related